☰

Claudio E. Chuaqui

Affiliations: 
Celegene 
Area:
Pharma
Google:
"Claudio Chuaqui"
Mean distance: 11.94
 		SNBCP
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Robert J. Le Roy grad student University of Waterloo

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Su Q, Banks E, Bebernitz G, et al. (2020) Discovery of (2R)-N-[3-[2-[(3-methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a potent and selective Janus Kinase 1 (JAK1) inhibitor. Journal of Medicinal Chemistry
Hu S, Marineau J, Hamman K, et al. (2019) Abstract 4421: SY-5609, an orally available selective CDK7 inhibitor demonstrates broad anti-tumor activity in vivo Cancer Research. 79: 4421-4421
Grimster NP, Anderson E, Alimzhanov M, et al. (2018) Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors. Journal of Medicinal Chemistry
McCoull W, Abrams RD, Anderson E, et al. (2017) Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors. Journal of Medicinal Chemistry
Kettle JG, Su Q, Grimster N, et al. (2017) Abstract 979: Discovery of the JAK1 selective kinase inhibitor AZD4205 Cancer Research. 77: 979-979
McCoull W, Hennessy EJ, Blades K, et al. (2016) Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors. Acs Medicinal Chemistry Letters. 7: 1118-1123
Akçay G, Belmonte MA, Aquila B, et al. (2016) Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain. Nature Chemical Biology
Hennessy EJ, Chuaqui C, Ashton S, et al. (2016) Utilization of Structure-Based Design to Identify Novel, Irreversible Inhibitors of EGFR Harboring the T790M Mutation. Acs Medicinal Chemistry Letters. 7: 514-519
Dowling JE, Alimzhanov M, Bao L, et al. (2016) Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo. Acs Medicinal Chemistry Letters. 7: 300-5
Vasbinder MM, Alimzhanov M, Augustin M, et al. (2015) Identification of azabenzimidazoles as potent JAK1 selective inhibitors. Bioorganic & Medicinal Chemistry Letters
See more...